Highlights Johnson & Johnson

Equities

JNJ

US4781601046

Real-time Estimate Cboe BZX Other stock markets 15:15:15 08/05/2024 BST			5-day change	1st Jan Change
149.4 ^USD	+0.48%		-1.32%	-4.82%

05-07	Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobs	RE
05-06	J&J: encouraging results in prostate cancer	CF

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobs	05-07	RE
J&J: encouraging results in prostate cancer	05-06	CF
J&J: positive results in bladder cancer	05-06	CF
Johnson & Johnson Announces Updated Results from an Open-Label, Multicenter, Multi-Cohort Phase 1 Study of the Safety and Efficacy of TAR-210	05-05	CI
Johnson & Johnson Says Erleada Combination Therapy Achieves 100% BCR-Free Rate	05-03	MT
Johnson & Johnson Announces Results from the Open-Label, Single-Arm Phase 2 Apa-RP Study Evaluating Adjuvant Treatment with ERLEADA and Androgen Deprivation Therapy	05-03	CI
Johnson & Johnson Announces Updated Results from Cohort 2 of the Phase 2b SunRISe-1 Study Evaluating the Efficacy and Safety of Investigational TAR-200 Monotherapy	05-03	CI
J&J: to present advances in retinal diseases	05-03	CF
Johnson & Johnson Highlights Commitment to Transform Treatment of Retinal Diseases at ARVO 2024	05-03	CI
Global markets live: Etsy, Qualcomm, Carvana, Rio Tinto, Apple...	05-02
Sector Update: Health Care Stocks Rise Late Afternoon	05-01	MT
Stocks rise after Fed rate decision, Powell press conference	05-01	RE
Sector Update: Health Care Stocks Advance Wednesday Afternoon	05-01	MT
Top Midday Stories: CVS Reports Q1 Earnings Miss, Lowers Outlook; ADP Q1 Earnings Top Estimates; J&J Proposes $6.5 Billion Settlement for Talc Lawsuits	05-01	MT
Johnson & Johnson Seeks EU Approval for Ulcerative Colitis, Crohn’s Disease Drug	05-01	MT
Nasdaq, S&P 500 fall as investors take cover before Fed decision	05-01	RE
Johnson & Johnson Announces $6.48 Billion Plan for Unit to Resolve Ovarian Cancer Talc Claims	05-01	MT
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday	05-01	MT
Sector Update: Health Care	05-01	MT
Johnson & Johnson Announces Plan For Subsidiary to Resolve Ovarian Cancer Talc Claims	05-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 05:30 pm